首页 › 基金 › Avidity Partners Management LP › CATX
Avidity Partners Management LP 对 CATX 的持仓历史
PERSPECTIVE THERAPEUTICS INC · 医疗保健
Avidity Partners Management LP 在 Q3 2026 的 13F 申报中披露持有 CATX(PERSPECTIVE THERAPEUTICS INC)6,067,999 股,市值约 US$16.7M,约占其申报组合的 4.25%,在其申报持仓中市值排名第 6 位。 Avidity Partners Management LP 最近 10 个申报季度中有 10 个季度披露了 CATX 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Avidity Partners Management LP 对 CATX 的持仓演变
Avidity Partners Management LP 于 Q2 2024 首次披露 CATX 持仓:3,037,668 股(约 US$30.3M)。 该持仓在 Q3 2024 达到峰值 3,444,002 股,市值约 US$46.0M。 在 10 次申报中,Avidity Partners Management LP 5 次增持、4 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 6,067,999 股、市值约 US$16.7M,环比减持 -232,000 股。。 持仓曾出现大幅变动:Q3 2025 增持约 61% (随后一个季度股价下跌 20%)、Q1 2026 增持约 88% (随后一个季度股价下跌 18%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 3.04M | $30.29M | 新进 |
| Q3 2024 | 3.44M | $45.98M | 增持 |
| Q4 2024 | 2.69M | $8.60M | 减持 |
| Q1 2025 | 2.20M | $4.68M | 减持 |
| Q2 2025 | 1.86M | $6.39M | 减持 |
| Q3 2025 | 2.99M | $10.27M | 增持 |
| Q4 2025 | 3.21M | $8.83M | 增持 |
| Q1 2026 | 6.05M | $25.23M | 增持 |
| Q2 2026 | 6.30M | $21.48M | 增持 |
| Q3 2026 | 6.07M | $16.69M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CATX 与 13F 数据
CATX(PERSPECTIVE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 CATX,申报仓位最大的包括:TCG Crossover Management, LLC (US$21.8M), Affinity Asset Advisors, LLC (US$11.0M), Spruce Street Capital LP (US$10.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CATX 的基金
- TCG Crossover Management, LLC 7.92M 股 · $21.77M · Q3 2026
- Affinity Asset Advisors, LLC 3.99M 股 · $10.97M · Q3 2026
- Spruce Street Capital LP 3.69M 股 · $10.16M · Q3 2026
- Nicholson Wealth Management Group, LLC 1.62M 股 · $4.45M · Q3 2026
- Yu Fan 1.06M 股 · $2.90M · Q3 2026
更多关于 Avidity Partners Management LP
常见问题
How long has Avidity Partners Management LP held CATX?
Avidity Partners Management LP has disclosed CATX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Avidity Partners Management LP's current position in CATX?
As of Q3 2026, Avidity Partners Management LP holds 6.07M shares of CATX (PERSPECTIVE THERAPEUTICS INC), valued at $16.69M, representing 4.25% of its reported portfolio and ranking #6.
Has Avidity Partners Management LP been buying or selling CATX?
In the latest 13F filing (Q3 2026), Avidity Partners Management LP reduced its position in CATX. The position peaked in Q3 2024 at 3.44M shares.
Which other funds hold CATX?
Other major institutional holders of CATX include TCG Crossover Management, LLC, Affinity Asset Advisors, LLC, Spruce Street Capital LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.